PFS
HRTX icon

Prospera Financial Services’s Heron Therapeutics HRTX Stock Holding History

Prospera Financial Services’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3K Hold
40,565
– – ﹤0.01% 1463
2026
Q1 		$32.5K Hold
40,565
– – ﹤0.01% 1411
2025
Q4 		$52.7K Sell
40,565
-11,100
-21% -$13.7K ﹤0.01% 1341
2025
Q3 		$65.1K Buy
51,665
+2,000
+4% +$3.17K ﹤0.01% 1338
2025
Q2 		$103K Buy
+49,665
New +$101K ﹤0.01% 1280
2020
Q4 		– Sell
-7,042
Closed -$104K – 1064
2020
Q3 		$104K Buy
+7,042
New +$110K 0.04% 396

Other funds holding HRTX

CPC
Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
AR
Apeiron RIA Dallas, Texas $390M AUM 22.97% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
TWM
TopTier Wealth Management Muskego, Wisconsin $166M AUM
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Prospera Financial Services's HRTX Position: Q2 2026 in Review

Prospera Financial Services held its Heron Therapeutics (HRTX) position steady in Q2 2026 at 40,565 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1463.

Prospera Financial Services first reported a position in HRTX in Q3 2020 and has held it in 6 quarters since. The position peaked at $104K in Q3 2020. 11 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Prospera Financial Services held 40,565 shares of Heron Therapeutics worth $17.3K as of Q2 2026.
  • Prospera Financial Services left its Heron Therapeutics share count unchanged in Q2 2026.
  • Heron Therapeutics made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1463 holding.
  • Prospera Financial Services first reported a position in Heron Therapeutics in Q3 2020 and has held it in 6 quarters since.
  • Prospera Financial Services's Heron Therapeutics position peaked at $104K in Q3 2020.
  • 11 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.